Kenmotsu H - Search Results

1

Chemotherapy-induced cardiomyopathy caused by Pemetrexed.

Oyakawa T, Iida K, Kusuhara M, Kenmotsu H, Sugino T. Oyakawa T, et al. Among authors: kenmotsu h. Invest New Drugs. 2018 Feb;36(1):147-150. doi: 10.1007/s10637-017-0485-5. Epub 2017 Jun 28. Invest New Drugs. 2018. PMID: 28660548

2

Antitumor activity of NK012 combined with cisplatin against small cell lung cancer and intestinal mucosal changes in tumor-bearing mouse after treatment.

Nagano T, Yasunaga M, Goto K, Kenmotsu H, Koga Y, Kuroda J, Nishimura Y, Sugino T, Nishiwaki Y, Matsumura Y. Nagano T, et al. Among authors: kenmotsu h. Clin Cancer Res. 2009 Jul 1;15(13):4348-55. doi: 10.1158/1078-0432.CCR-08-3334. Epub 2009 Jun 9. Clin Cancer Res. 2009. PMID: 19509138

3

Antitumor effect of NK012, a 7-ethyl-10-hydroxycamptothecin-incorporating polymeric micelle, on U87MG orthotopic glioblastoma in mice compared with irinotecan hydrochloride in combination with bevacizumab.

Kuroda J, Kuratsu J, Yasunaga M, Koga Y, Kenmotsu H, Sugino T, Matsumura Y. Kuroda J, et al. Among authors: kenmotsu h. Clin Cancer Res. 2010 Jan 15;16(2):521-9. doi: 10.1158/1078-0432.CCR-09-2393. Epub 2010 Jan 12. Clin Cancer Res. 2010. PMID: 20068081

4

Synergistic antitumor activity of the SN-38-incorporating polymeric micelles NK012 with S-1 in a mouse model of non-small cell lung cancer.

Nagano T, Yasunaga M, Goto K, Kenmotsu H, Koga Y, Kuroda J, Nishimura Y, Sugino T, Nishiwaki Y, Matsumura Y. Nagano T, et al. Among authors: kenmotsu h. Int J Cancer. 2010 Dec 1;127(11):2699-706. doi: 10.1002/ijc.25282. Int J Cancer. 2010. PMID: 20198621 Free article.

5

The risk of cytotoxic chemotherapy-related exacerbation of interstitial lung disease with lung cancer.

Kenmotsu H, Naito T, Kimura M, Ono A, Shukuya T, Nakamura Y, Tsuya A, Kaira K, Murakami H, Takahashi T, Endo M, Yamamoto N. Kenmotsu H, et al. J Thorac Oncol. 2011 Jul;6(7):1242-6. doi: 10.1097/JTO.0b013e318216ee6b. J Thorac Oncol. 2011. PMID: 21623239 Free article.

6

Acute lung injury with alveolar hemorrhage as adverse drug reaction related to crizotinib.

Ono A, Takahashi T, Oishi T, Sugino T, Akamatsu H, Shukuya T, Taira T, Kenmotsu H, Naito T, Murakami H, Nakajima T, Endo M, Yamamoto N. Ono A, et al. Among authors: kenmotsu h. J Clin Oncol. 2013 Sep 10;31(26):e417-9. doi: 10.1200/JCO.2012.47.1110. Epub 2013 Jul 15. J Clin Oncol. 2013. PMID: 23857970 No abstract available.

7

Toxicity and efficacy of chemotherapy for non-small cell lung cancer with cavitary lesions.

Tokito T, Shukuya T, Akamatsu H, Ono A, Taira T, Kenmotsu H, Naito T, Murakami H, Takahashi T, Endo M, Mori K, Yamamoto N. Tokito T, et al. Among authors: kenmotsu h. Respir Investig. 2014 May;52(3):184-9. doi: 10.1016/j.resinv.2013.12.004. Epub 2014 Jan 17. Respir Investig. 2014. PMID: 24853019

8

The effect of gefitinib in patients with postoperative recurrent non-small cell lung cancer harboring mutations of the epidermal growth factor receptor.

Ko R, Kenmotsu H, Hisamatsu Y, Akamatsu H, Omori S, Nakashima K, Oyakawa T, Wakuda K, Shukuya T, Ono A, Imai H, Taira T, Naito T, Murakami H, Mori K, Endo M, Ohde Y, Takahashi K, Takahashi T. Ko R, et al. Among authors: kenmotsu h. Int J Clin Oncol. 2015 Aug;20(4):668-73. doi: 10.1007/s10147-014-0761-8. Epub 2014 Oct 25. Int J Clin Oncol. 2015. PMID: 25343946

9

Prognostic impact of cancer cachexia in patients with advanced non-small cell lung cancer.

Kimura M, Naito T, Kenmotsu H, Taira T, Wakuda K, Oyakawa T, Hisamatsu Y, Tokito T, Imai H, Akamatsu H, Ono A, Kaira K, Murakami H, Endo M, Mori K, Takahashi T, Yamamoto N. Kimura M, et al. Among authors: kenmotsu h. Support Care Cancer. 2015 Jun;23(6):1699-708. doi: 10.1007/s00520-014-2534-3. Epub 2014 Nov 29. Support Care Cancer. 2015. PMID: 25430482

10

The efficacy of amrubicin on central nervous system metastases originating from small-cell lung cancer: a case series of eight patients.

Miura S, Kaira K, Kaira R, Akamatsu H, Ono A, Shukuya T, Tsuya A, Nakamura Y, Kenmotsu H, Naito T, Murakami H, Takahashi T, Endo M, Yamamoto N. Miura S, et al. Among authors: kenmotsu h. Invest New Drugs. 2015 Jun;33(3):755-60. doi: 10.1007/s10637-015-0233-7. Epub 2015 Apr 7. Invest New Drugs. 2015. PMID: 25846908

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

273 results

Search Page